ResearcherResearch Institute Hospital 12 de OctubreActive in the last 2 years

Paula Iglesias-Matesanz

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5114693408. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2024: 1 paper

Papers 1

Glutathione Peroxidases: An Emerging and Promising Therapeutic Target for Pancreatic Cancer Treatment. Co-author DOI 10.3390/antiox13111405 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Michael Ochieng’ Otieno · 1 shared paper, 2024 · strength 0.26
- Paper Glutathione Peroxidases: An Emerging and Promising Therapeutic Target for Pancreatic Cancer Treatment. DOI 10.3390/antiox13111405 ↗
Carlos Lopez-Blazquez · 1 shared paper, 2024 · strength 0.26
- Paper Glutathione Peroxidases: An Emerging and Promising Therapeutic Target for Pancreatic Cancer Treatment. DOI 10.3390/antiox13111405 ↗
Carlos Lacalle-González · 1 shared paper, 2024 · strength 0.26
- Paper Glutathione Peroxidases: An Emerging and Promising Therapeutic Target for Pancreatic Cancer Treatment. DOI 10.3390/antiox13111405 ↗
Jesús García‐Foncillas · 1 shared paper, 2024 · strength 0.26
- Paper Glutathione Peroxidases: An Emerging and Promising Therapeutic Target for Pancreatic Cancer Treatment. DOI 10.3390/antiox13111405 ↗
Javier Martínez‐Useros · 1 shared paper, 2024 · strength 0.26
- Paper Glutathione Peroxidases: An Emerging and Promising Therapeutic Target for Pancreatic Cancer Treatment. DOI 10.3390/antiox13111405 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.